{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T15:06:18Z","timestamp":1790867178846,"version":"4.1.0"},"reference-count":82,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,7]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Multidrug-resistant tuberculosis (MDR-TB) is a serious threat to global tuberculosis (TB) control efforts. This study aims to investigate the trend of MDR-TB prevalence in Iran over 20 years.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>A systematic literature search was conducted in various databases, including PubMed, Embase, and Web of Science, from 1981 to 2023. Studies reporting the prevalence of MDR-TB in Iran were included in the meta-analysis. Statistical analysis was performed using Comprehensive Meta-Analysis software.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      A total of 58 studies from different provinces of Iran were included in the meta-analysis. The majority of studies were from Tehran (\n                      <jats:italic toggle=\"yes\">n<\/jats:italic>\n                      = 33), Kermanshah (\n                      <jats:italic toggle=\"yes\">n<\/jats:italic>\n                      = 5), Mashhad (\n                      <jats:italic toggle=\"yes\">n<\/jats:italic>\n                      = 4), and Tabriz (\n                      <jats:italic toggle=\"yes\">n<\/jats:italic>\n                      = 4) provinces. Overall, 1885 cases of MDR-TB were reported in Iran during the study period. The highest number of MDR-TB cases was reported in 2000 (582 cases) and the lowest in 2001 (1 case). An increasing trend in MDR-TB prevalence was observed, particularly between 2018 and 2019. The pooled prevalence of MDR-TB in Iran was 12.31% (95% CI: 11.83\u201312.80) using the fixed-effects model and 20.21% (95% CI: 15.70\u201326.01) using the random-effects model. No evidence of publication bias was found.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>The results of this comprehensive meta-analysis highlight the increasing trend of MDR-TB in Iran over the past two decades. This underscores the urgent need for strengthening TB control strategies, including improved surveillance, case detection, treatment, and management of MDR-TB in the country. Developing diagnostic and treatment approaches for MDR-TB should be prioritized by Iranian medical universities and public health authorities.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/ijmy.ijmy_162_24","type":"journal-article","created":{"date-parts":[[2024,9,15]],"date-time":"2024-09-15T16:00:50Z","timestamp":1726416050000},"page":"320-330","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":11,"title":["Prevalence and Temporal Trends of Multidrug-resistant Tuberculosis in Iran from 1981 to 2023: A Systematic Review and Meta-analysis"],"prefix":"10.4103","volume":"13","author":[{"given":"Saman","family":"Ayoubi","sequence":"first","affiliation":[{"name":"Mycobacteriology Research Center (MRC), National Research Institute of Tuberculosis and Lung Disease (NRITLD), Shahid Beheshti University of Medical Sciences, Tehran, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3676-2018","authenticated-orcid":false,"given":"Parissa","family":"Farnia","sequence":"additional","affiliation":[{"name":"Mycobacteriology Research Center (MRC), National Research Institute of Tuberculosis and Lung Disease (NRITLD), Shahid Beheshti University of Medical Sciences, Tehran, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Poopak","family":"Farnia","sequence":"additional","affiliation":[{"name":"Mycobacteriology Research Center (MRC), National Research Institute of Tuberculosis and Lung Disease (NRITLD), Shahid Beheshti University of Medical Sciences, Tehran, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jalaledin","family":"Ghanavi","sequence":"additional","affiliation":[{"name":"Mycobacteriology Research Center (MRC), National Research Institute of Tuberculosis and Lung Disease (NRITLD), Shahid Beheshti University of Medical Sciences, Tehran, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali Akbar","family":"Velayati","sequence":"additional","affiliation":[{"name":"Mycobacteriology Research Center (MRC), National Research Institute of Tuberculosis and Lung Disease (NRITLD), Shahid Beheshti University of Medical Sciences, Tehran, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2024,9,14]]},"reference":[{"key":"R1-20241212","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.jiph.2010.11.002","article-title":"First insight into the drug resistance pattern of Mycobacterium tuberculosis in Dohuk, Iraq: Using spoligotyping and MIRU-VNTR to characterize multidrug resistant strains","volume":"4","author":"Merza","year":"2011","journal-title":"J Infect Public Health"},{"key":"R2-20241212","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.jinf.2005.12.020","article-title":"Prevalence of Haarlem I and Beijing types of Mycobacterium tuberculosis strains in Iranian and Afghan MDR-TB patients","volume":"53","author":"Farnia","year":"2006","journal-title":"J Infect"},{"key":"R3-20241212","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/j.cegh.2019.12.002","article-title":"An 8-year study on the prevalence and drug resistance of mycobacteria in clinical specimens (2011\u20132018)","volume":"8","author":"Aghajani","year":"2020","journal-title":"Clin Epidemiol Glob Health"},{"key":"R4-20241212","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1086\/507542","article-title":"Extensively drug-resistant tuberculosis: 2 years of surveillance in Iran","volume":"43","author":"Masjedi","year":"2006","journal-title":"Clin Infect Dis"},{"key":"R5-20241212","doi-asserted-by":"crossref","first-page":"90","DOI":"10.52547\/hsm.2.2.90","article-title":"Prediction of multidrug-resistant tuberculosis in tuberculosis patients using perceptron artificial neural networks model","volume":"2","author":"Kazempour","year":"2023","journal-title":"Health Sci Monit"},{"key":"R6-20241212","doi-asserted-by":"crossref","first-page":"e236","DOI":"10.1016\/j.ijid.2008.11.027","article-title":"First-line anti-tuberculosis drug resistance patterns and trends at the national TB referral center in Iran \u2013 Eight years of surveillance","volume":"13","author":"Shamaei","year":"2009","journal-title":"Int J Infect Dis"},{"key":"R7-20241212","first-page":"165","article-title":"Rapid identification of extensively and extremely drug resistant tuberculosis from multidrug resistant strains; using PCR-RFLP and PCR-SSCP","volume":"4","author":"Tahmasebi","year":"2012","journal-title":"Iran J Microbiol"},{"key":"R8-20241212","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1111\/j.1440-1843.2007.01201.x","article-title":"Representative drug susceptibility patterns for guiding design of re-treatment regimens for multidrug-resistant tuberculosis in Iran","volume":"13","author":"Tabarsi","year":"2008","journal-title":"Respirology"},{"key":"R9-20241212","first-page":"544","article-title":"Trends of drug resistant Mycobacterium tuberculosis in a tertiary tuberculosis center in Iran","volume":"28","author":"Mirsaeidi","year":"2007","journal-title":"Saudi Med J"},{"key":"R10-20241212","first-page":"17","article-title":"Risk factors associated with multidrug-resistant tuberculosis","volume":"8","author":"Baghaei","year":"2009","journal-title":"TANAFFOS"},{"key":"R11-20241212","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.bjid.2012.10.011","article-title":"Multidrug resistant tuberculosis versus non-tuberculous mycobacterial infections: A CT-scan challenge","volume":"17","author":"Kahkouee","year":"2013","journal-title":"Braz J Infect Dis"},{"key":"R12-20241212","first-page":"47","article-title":"Pattern of drug resistance in pulmonary TB patients","volume":"2","author":"Amiri","year":"2003","journal-title":"TANAFFOS (Respiration)"},{"key":"R13-20241212","first-page":"97","article-title":"Rapid detection of isoniazid resistance in Mycobacterium tuberculosis by a single multiplex allele-specific polymerase chain reaction assay","volume":"13","author":"Taghavi","year":"2011","journal-title":"Cell J"},{"key":"R14-20241212","doi-asserted-by":"crossref","first-page":"116","DOI":"10.24171\/j.phrp.2017.8.2.03","article-title":"Low levels of extensively drug-resistant tuberculosis among multidrug resistant tuberculosis isolates and their relationship to risk factors: Surveillance in Tehran, Iran; 2006 to 2014","volume":"8","author":"Tasbiti","year":"2017","journal-title":"Osong Public Health Res Perspect"},{"key":"R15-20241212","doi-asserted-by":"crossref","first-page":"100981","DOI":"10.1016\/j.genrep.2020.100981","article-title":"The frequency of point mutations associated with resistance to isoniazid and rifampin among clinical isolates of multidrug-resistant Mycobacterium tuberculosis in the West of Iran","volume":"22","author":"Hamed","year":"2021","journal-title":"Gene Rep"},{"key":"R16-20241212","doi-asserted-by":"crossref","first-page":"99","DOI":"10.4269\/ajtmh.13-0057","article-title":"High prevelance of rifampin-monoresistant tuberculosis: A retrospective analysis among Iranian pulmonary tuberculosis patients","volume":"90","author":"Velayati","year":"2014","journal-title":"Am J Trop Med Hyg"},{"key":"R17-20241212","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.jgar.2016.01.007","article-title":"Haarlem 3 is the predominant genotype family in multidrug-resistant and extensively drug-resistant Mycobacterium tuberculosis in the capital of Iran: A 5-year survey","volume":"5","author":"Khanipour","year":"2016","journal-title":"J Glob Antimicrob Resist"},{"key":"R18-20241212","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1016\/j.kjms.2017.06.011","article-title":"Genetic diversity of multidrug-resistant Mycobacterium tuberculosis strains isolated from tuberculosis patients in Iran using MIRU-VNTR technique","volume":"33","author":"Khosravi","year":"2017","journal-title":"Kaohsiung J Med Sci"},{"key":"R19-20241212","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1128\/JCM.01435-07","article-title":"Colorimetric detection of multidrug-resistant or extensively drug-resistant tuberculosis by use of malachite green indicator dye","volume":"46","author":"Farnia","year":"2008","journal-title":"J Clin Microbiol"},{"key":"R20-20241212","first-page":"57","article-title":"IL-10 and IL-12 production in response to Mycobacterium tuberculosis total lipid antigens in multidrug resistant tuberculosis","volume":"7","author":"Shams","year":"2010","journal-title":"Iran J Immunol"},{"key":"R21-20241212","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.jgar.2017.06.010","article-title":"Distribution scheme of antituberculosis drug resistance among HIV patients in a referral Centre over 10 years","volume":"11","author":"Baghaei","year":"2017","journal-title":"J Glob Antimicrob Resist"},{"key":"R22-20241212","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.jgar.2018.12.022","article-title":"Direct drug susceptibility testing of Mycobacterium tuberculosis using the proportional method: A multicenter study","volume":"17","author":"Amini","year":"2019","journal-title":"J Glob Antimicrob Resist"},{"key":"R23-20241212","doi-asserted-by":"crossref","first-page":"161","DOI":"10.34172\/aim.2022.27","article-title":"A report on drug resistance patterns of Mycobacterium tuberculosis isolates in Northern Iran","volume":"25","author":"Mansoori","year":"2022","journal-title":"Arch Iran Med"},{"key":"R24-20241212","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1080\/0036554021000026990a","article-title":"Multidrug-resistant strains of Mycobacterium tuberculosis isolated from patients in Tehran belong to a genetically distinct cluster","volume":"35","author":"Feizabadi","year":"2003","journal-title":"Scand J Infect Dis"},{"key":"R25-20241212","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1017\/S0950268806006790","article-title":"Instability of IS6110 patterns in multidrug-resistant strains of Mycobacterium tuberculosis","volume":"135","author":"Farnia","year":"2007","journal-title":"Epidemiol Infect"},{"key":"R26-20241212","doi-asserted-by":"crossref","first-page":"1","DOI":"10.5812\/archcid.82828","article-title":"Prevalence of multidrug-resistant tuberculosis: A six-year single-center retrospective study in Tehran, Iran","volume":"14","author":"Habibnia","year":"2019","journal-title":"Arch Clin Infect Dis"},{"key":"R27-20241212","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/S1995-7645(14)60019-5","article-title":"Drug resistance pattern of Mycobacterium tuberculosis isolates from patients of five provinces of Iran","volume":"7","author":"Nasiri","year":"2014","journal-title":"Asian Pac J Trop Med"},{"key":"R28-20241212","doi-asserted-by":"crossref","first-page":"114","DOI":"10.4103\/0974-777X.138506","article-title":"Anti tuberculosis drug resistance in West of Iran","volume":"6","author":"Mohajeri","year":"2014","journal-title":"J Glob Infect Dis"},{"key":"R29-20241212","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1128\/JCM.01477-18","article-title":"Genetic diversity of multi- and extensively drug-resistant Mycobacterium tuberculosis isolates in the capital of Iran, revealed by whole-genome sequencing","volume":"57","author":"Vaziri","year":"2019","journal-title":"J Clin Microbiol"},{"key":"R30-20241212","first-page":"154","article-title":"Outcomes following surgery for complicated tuberculosis: Analysis of 108 patients","volume":"61","author":"Bagheri","year":"2013","journal-title":"Thorac Cardiovasc Surg"},{"key":"R31-20241212","doi-asserted-by":"crossref","first-page":"100767","DOI":"10.1016\/j.nmni.2020.100767","article-title":"Molecular epidemiology of Mycobacterium tuberculosis isolates in Iran using spoligotyping","volume":"38","author":"Ramazanzadeh","year":"2020","journal-title":"New Microbes New Infect"},{"key":"R32-20241212","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1186\/s12879-020-05112-5","article-title":"Genotypic and phenotypic characterization of Mycobacterium tuberculosis resistance against fluoroquinolones in the Northeast of Iran","volume":"20","author":"Sayadi","year":"2020","journal-title":"BMC Infect Dis"},{"key":"R33-20241212","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1099\/jmm.0.46442-0","article-title":"Rapid and low-cost colorimetric method using 2,3,5-triphenyltetrazolium chloride for detection of multidrug-resistant Mycobacterium tuberculosis","volume":"55","author":"Mohammadzadeh","year":"2006","journal-title":"J Med Microbiol"},{"key":"R34-20241212","doi-asserted-by":"crossref","first-page":"100879","DOI":"10.1016\/j.nmni.2021.100879","article-title":"Detection of genomic mutations in katG and rpoB genes among multidrug-resistant Mycobacterium tuberculosis isolates from Tehran, Iran","volume":"41","author":"Motavaf","year":"2021","journal-title":"New Microbes New Infect"},{"key":"R35-20241212","first-page":"654","article-title":"Resistance to first-line drugs in clinical isolates of Mycobacterium tuberculosis in Isfahan","volume":"40","author":"Farzaneh","year":"2022","journal-title":"J Isfahan Med Sch"},{"key":"R36-20241212","doi-asserted-by":"crossref","first-page":"S165","DOI":"10.12980\/APJTB.4.2014C1186","article-title":"Rapid detection of MDR-Mycobacterium tuberculosis using modified PCR-SSCP from clinical specimens","volume":"4","author":"Ali","year":"2014","journal-title":"Asian Pac J Trop Biomed"},{"key":"R37-20241212","doi-asserted-by":"crossref","first-page":"363","DOI":"10.3855\/jidc.7215","article-title":"Frequency of mutational changes in the embB among the ethambutol-resistant strains of Mycobacterium tuberculosis in Iran","volume":"10","author":"Rezaei","year":"2016","journal-title":"J Infect Dev Ctries"},{"key":"R38-20241212","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/j.cegh.2018.09.006","article-title":"Determinant factors of drug resistant tuberculosis in Iran, a case control study","volume":"7","author":"Afshari","year":"2019","journal-title":"Clin Epidemiol Glob Health"},{"key":"R39-20241212","first-page":"320","article-title":"Genotypic diversity of resistant Mycobacterium tuberculosis strains isolated from tuberculosis patients in East Azerbaijan center by MIRU-VNTR","volume":"11","author":"Afaghi-Garaaleki","year":"2019","journal-title":"J Microb World"},{"key":"R40-20241212","first-page":"3091","article-title":"Study prevalence of multidrug-resistant (MDR) and extensively drug-resistant (XDR) tuberculosis in East Azerbaijan province of Iran","volume":"6","author":"Mehdi","year":"2012","journal-title":"HealthMED"},{"key":"R41-20241212","first-page":"909","article-title":"Primary and acquired drug resistance in childhood tuberculosis","volume":"12","author":"Khalilzadeh","year":"2006","journal-title":"East Mediterr Health J"},{"key":"R42-20241212","first-page":"DC9","article-title":"Molecular identification of mutations associated with pyrazinamide-resistance in multidrug-resistant tuberculosis in eight provinces of Iran","volume":"11","author":"Moradi","year":"2017","journal-title":"J Clin Diagn Res"},{"key":"R43-20241212","first-page":"254","article-title":"Limited transmission of multidrug-resistant tuberculosis in East Azarbaijan, Iran","volume":"3","author":"Asgharzadeh","year":"2014","journal-title":"Beni-Suef Univ J Basic Appl Sci"},{"key":"R44-20241212","doi-asserted-by":"crossref","first-page":"3437","DOI":"10.2147\/IDR.S221823","article-title":"Comparison of drrA and drrB efflux pump genes expression in drug-susceptible and -resistant Mycobacterium tuberculosis strains isolated from tuberculosis patients in Iran","volume":"12","author":"Khosravi","year":"2019","journal-title":"Infect Drug Resist"},{"key":"R45-20241212","first-page":"747085","article-title":"Epidemiological characterization of drug resistance among Mycobacterium tuberculosis isolated from patients in Northeast of Iran during 2012-2013","volume":"2015","author":"Tavanaee","year":"2015","journal-title":"Biomed Res Int"},{"key":"R46-20241212","doi-asserted-by":"crossref","first-page":"1","DOI":"10.5812\/archcid.81436","article-title":"Molecular detection of isoniazid and rifampin resistance in Mycobacterium tuberculosis isolates from lorestan province, Iran from 2014 to 2017","volume":"15","author":"Heidary","year":"2020","journal-title":"Arch Clin Infect Dis"},{"key":"R47-20241212","doi-asserted-by":"crossref","first-page":"29","DOI":"10.2174\/1874306401610010029","article-title":"Patterns of drug resistance among tuberculosis patients in West and Northwestern Iran","volume":"10","author":"Sahebi","year":"2016","journal-title":"Open Respir Med J"},{"key":"R48-20241212","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.phrp.2015.10.010","article-title":"Drug resistance pattern of Mycobacterium tuberculosis isolates from patients referred to TB reference laboratory in Ahvaz","volume":"7","author":"Badie","year":"2016","journal-title":"Osong Public Health Res Perspect"},{"key":"R49-20241212","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.phrp.2016.01.003","article-title":"Rapid detection of rifampicin- and isoniazid-resistant Mycobacterium tuberculosis using TaqMan allelic discrimination","volume":"7","author":"Darban-Sarokhalil","year":"2016","journal-title":"Osong Public Health Res Perspect"},{"key":"R50-20241212","doi-asserted-by":"crossref","first-page":"2073","DOI":"10.2147\/IDR.S255889","article-title":"Spoligotype and drug susceptibility profiles of Mycobacterium tuberculosis complex isolates in golestan province, North Iran","volume":"13","author":"Mansoori","year":"2020","journal-title":"Infect Drug Resist"},{"key":"R51-20241212","first-page":"101","article-title":"Multidrug-resistant tuberculosis in North-West of Iran and republic of Azerbaijan: A major public health concern for Iranian people","volume":"15","author":"Rashedi","year":"2015","journal-title":"J Res Health Sci"},{"key":"R52-20241212","first-page":"77","article-title":"Prevalence of primary drug resistant Mycobacterium tuberculosis in Mashhad, Iran","volume":"124","author":"Namaei","year":"2006","journal-title":"Indian J Med Res"},{"key":"R53-20241212","doi-asserted-by":"crossref","first-page":"112","DOI":"10.4103\/bbrj.bbrj_26_18","article-title":"Epidemiology of multi-drug-resistant tuberculosis in Northern India","volume":"2","author":"Kumar","year":"2018","journal-title":"Biomed Biotechnol Res J (BBRJ)"},{"key":"R54-20241212","doi-asserted-by":"crossref","first-page":"98","DOI":"10.4103\/bbrj.bbrj_178_21","article-title":"Antibacterial and antibiofilm properties of Azadirachta indica (Neem), Aloe vera (Aloe vera), and Mentha piperita (Peppermint) against multidrug-resistant clinical isolates","volume":"6","author":"Mehrishi","year":"2022","journal-title":"Biomed Biotechnol Res J"},{"key":"R55-20241212","doi-asserted-by":"crossref","first-page":"400","DOI":"10.4103\/bbrj.bbrj_104_22","article-title":"Synthesis of silver nanoparticles using Nigella sativa seed extract and its efficacy against some multidrug-resistant uropathogens","volume":"6","author":"Ezeh","year":"2022","journal-title":"Biomed Biotechnol Res J (BBRJ)"},{"key":"R56-20241212","doi-asserted-by":"crossref","first-page":"295","DOI":"10.4103\/bbrj.bbrj_113_18","article-title":"Genetic mutations at rifampicin resistance-determining region of RpoB gene in conferring resistance to isolated multidrug-resistant tuberculosis strains","volume":"2","author":"Das","year":"2018","journal-title":"Biomed Biotechnol Res J (BBRJ)"},{"key":"R57-20241212","doi-asserted-by":"crossref","first-page":"175","DOI":"10.4103\/bbrj.bbrj_270_21","article-title":"Evaluation of biofilm formation and antibiotic resistance pattern in extended-spectrum \u03b2-lactamase-producing Escherichia coli strains","volume":"6","author":"Jomehzadeh","year":"2022","journal-title":"Biomed Biotechnol Res J (BBRJ)"},{"key":"R58-20241212","doi-asserted-by":"crossref","first-page":"16","DOI":"10.4103\/bbrj.bbrj_108_17","article-title":"Anti-tuberculosis therapy: Urgency for new drugs and integrative approach","volume":"2","author":"Jena","year":"2018","journal-title":"Biomed Biotechnol Res J (BBRJ)"},{"key":"R59-20241212","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.ijmyco.2012.07.007","article-title":"Risk factors for multidrug-resistant tuberculosis in urban Pakistan: A multicenter case-control study","volume":"1","author":"Ahmad","year":"2012","journal-title":"Int J Mycobacteriol"},{"key":"R60-20241212","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.ijmyco.2015.11.001","article-title":"Previous treatment, sputum-smear nonconversion, and suburban living: The risk factors of multidrug-resistant tuberculosis among Malaysians","volume":"5","author":"Mohd","year":"2016","journal-title":"Int J Mycobacteriol"},{"key":"R61-20241212","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.ijmyco.2016.08.008","article-title":"Epidemiology of multidrug-resistant, extensively drug resistant, and totally drug resistant tuberculosis in Middle East countries","volume":"5","author":"Ahmed","year":"2016","journal-title":"Int J Mycobacteriol"},{"key":"R62-20241212","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.ijmyco.2015.12.004","article-title":"A cross-sectional study about knowledge and attitudes toward multidrug-resistant and extensively drug-resistant tuberculosis in a high-burden drug-resistant country","volume":"5","author":"Javed","year":"2016","journal-title":"Int J Mycobacteriol"},{"key":"R63-20241212","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.ijmyco.2014.11.030","article-title":"Pyrazinamide resistance in Swedish multidrug-resistant tuberculosis 2003-2013","volume":"4","author":"Mansj\u00f6","year":"2015","journal-title":"Int J Mycobacteriol"},{"issue":"Suppl 1","key":"R64-20241212","doi-asserted-by":"crossref","first-page":"S62","DOI":"10.1016\/j.ijmyco.2016.11.014","article-title":"Bedaquiline in the multidrug-resistant tuberculosis treatment: Belarus experience","volume":"5","author":"Skrahina","year":"2016","journal-title":"Int J Mycobacteriol"},{"key":"R65-20241212","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/j.ijmyco.2016.07.007","article-title":"More than half of presumptive multidrug-resistant cases referred to a tuberculosis referral laboratory in the Tigray region of Ethiopia are multidrug resistant","volume":"5","author":"Tesfay","year":"2016","journal-title":"Int J Mycobacteriol"},{"key":"R66-20241212","doi-asserted-by":"crossref","first-page":"76","DOI":"10.4103\/jpdtsm.jpdtsm_6_22","article-title":"Coronavirus disease 2019 and Mycobacterium tuberculosis reactivation and coinfections: A review of the literature","volume":"1","author":"Daneshmandi","year":"2022","journal-title":"J Prev Diagn Treat Strateg Med"},{"key":"R67-20241212","doi-asserted-by":"crossref","first-page":"96","DOI":"10.4103\/jpdtsm.jpdtsm_40_22","article-title":"Isoniazid nano-drug delivery systems targeting macrophages for the treatment of tuberculosis","volume":"1","author":"Vemula","year":"2022","journal-title":"J Prev Diagn Treat Strateg Med"},{"key":"R68-20241212","doi-asserted-by":"crossref","first-page":"21","DOI":"10.4103\/jpdtsm.jpdtsm_3_22","article-title":"Potential approaches for the diagnosis and treatment of drug-resistant leprosy","volume":"1","author":"Lavania","year":"2022","journal-title":"J Prev Diagn Treat Strateg Med"},{"key":"R69-20241212","doi-asserted-by":"crossref","first-page":"202","DOI":"10.4103\/jpdtsm.jpdtsm_55_22","article-title":"Pharmacognostical and phytopharmacological review on coatbuttons","volume":"1","author":"Selvakumar","year":"2022","journal-title":"J Prev Diagn Treat Strateg Med"},{"issue":"Suppl 1","key":"R70-20241212","doi-asserted-by":"crossref","first-page":"S21","DOI":"10.1016\/j.ijmyco.2016.09.044","article-title":"Host-directed therapies for multidrug resistant tuberculosis","volume":"5","author":"Zumla","year":"2016","journal-title":"Int J Mycobacteriol"},{"issue":"Suppl 1","key":"R71-20241212","doi-asserted-by":"crossref","first-page":"S36","DOI":"10.1016\/j.ijmyco.2016.11.020","article-title":"Investigation of isoniazid and ethionamide cross-resistance by whole genome sequencing and association with poor treatment outcomes of multidrug-resistant tuberculosis patients in South Africa","volume":"5","author":"Malinga","year":"2016","journal-title":"Int J Mycobacteriol"},{"key":"R72-20241212","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.ijmyco.2014.10.010","article-title":"The longitudinal trends of multidrug and extensively drug resistant tuberculosis in China","volume":"4","author":"Hu","year":"2015","journal-title":"Int J Mycobacteriol"},{"key":"R73-20241212","doi-asserted-by":"crossref","first-page":"e33863","DOI":"10.1016\/j.heliyon.2024.e33863","article-title":"Mycobacterium tuberculosis and rifampicin-resistant tuberculosis among tuberculosis presumptive patients in selected zones of Tigray, Northern Ethiopia, 2016-2019","volume":"10","author":"Dejene","year":"2024","journal-title":"Heliyon"},{"key":"R74-20241212","doi-asserted-by":"crossref","first-page":"4137","DOI":"10.2147\/IDR.S373125","article-title":"Drug resistance patterns and trends in patients with suspected drug-resistant tuberculosis in Dalian, China: A retrospective study","volume":"15","author":"Pan","year":"2022","journal-title":"Infect Drug Resist"},{"key":"R75-20241212","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.jgar.2019.03.009","article-title":"Drug resistance profile of Mycobacterium tuberculosis and predictors associated with the development of drug resistance","volume":"18","author":"Hameed","year":"2019","journal-title":"J Glob Antimicrob Resist"},{"key":"R76-20241212","doi-asserted-by":"crossref","first-page":"659","DOI":"10.7196\/SAMJ.2019.v109i9.13730","article-title":"Prevalence of isoniazid resistance-conferring mutations associated with multidrug-resistant tuberculosis in Free State Province, South Africa","volume":"109","author":"Pitso","year":"2019","journal-title":"S Afr Med J"},{"key":"R77-20241212","doi-asserted-by":"crossref","first-page":"111","DOI":"10.4103\/ijmbs.ijmbs_41_19","article-title":"Prevalence of multi-drug-resistant tuberculosis among human immunodeficiency virus and nonhuman immunodeficiency virus-positive pulmonary tuberculosis patients of two referral hospitals in Southeast Nigeria","volume":"11","author":"Okoro","year":"2019","journal-title":"Ibnosina J Med Biomed Sci"},{"key":"R78-20241212","doi-asserted-by":"crossref","first-page":"59","DOI":"10.4103\/bbrj.bbrj_7_17","article-title":"High moxifloxacin cross-resistance levels among \u201cnewly identified\u201d ofloxacin-resistant multidrug-resistant tuberculosis patients from South India: A ticking bomb or a tricky challenge?","volume":"1","author":"Sanker","year":"2017","journal-title":"Biomed Biotechnol Res J (BBRJ)"},{"key":"R79-20241212","doi-asserted-by":"crossref","first-page":"87","DOI":"10.4103\/bbrj.bbrj_53_19","article-title":"Second-line drug susceptibilities of multidrug-and rifampicin-resistant Mycobacterium tuberculosis isolates in Delhi","volume":"3","author":"Sidiq","year":"2019","journal-title":"Biomed Biotechnol Res J (BBRJ)"},{"key":"R80-20241212","doi-asserted-by":"crossref","first-page":"71","DOI":"10.4103\/jpdtsm.jpdtsm_5_24","article-title":"Comparative analysis of microscopic and real-time polymerase chain reaction-based methods for the detection of multidrug resistance in Mycobacterium tuberculosis","volume":"3","author":"Dave","year":"2024","journal-title":"J Prev Diagn Treat Strateg Med"},{"key":"R81-20241212","doi-asserted-by":"crossref","first-page":"236","DOI":"10.4103\/jpdtsm.jpdtsm_133_23","article-title":"Evaluating diagnostic utility of genexpert ultra (Mycobacterium tuberculosis\/rifampicin), microscopy and liquid culture to isolate Mycobacterium tuberculosis and nontuberculous mycobacteria among pulmonary tuberculosis suspects","volume":"2","author":"Gota","year":"2023","journal-title":"J Prev Diagn Treat Strateg Med"},{"key":"R82-20241212","doi-asserted-by":"crossref","first-page":"37","DOI":"10.4103\/jpdtsm.jpdtsm_144_23","article-title":"Tuberculosis prevention, diagnosis, and treatment financial profile during 2006-2021: Part B","volume":"3","author":"Madadi-Goli","year":"2024","journal-title":"J Prev Diagn Treat Strateg Med"}],"container-title":["The International Journal of Mycobacteriology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/ijmy.ijmy_162_24","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T19:40:32Z","timestamp":1787773232000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/ijmy.ijmy_162_24"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7]]},"references-count":82,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.4103\/ijmy.ijmy_162_24","relation":{},"ISSN":["2212-5531","2212-554X"],"issn-type":[{"value":"2212-5531","type":"print"},{"value":"2212-554X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,7]]},"assertion":[{"value":"2024-05-10","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-08-18","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}